178 related articles for article (PubMed ID: 5699094)
1. Prevention of ventricular fibrillation induced by coronary ligation.
Kaumann AJ; Aramendía P
J Pharmacol Exp Ther; 1968 Dec; 164(2):326-32. PubMed ID: 5699094
[No Abstract] [Full Text] [Related]
2. Some effects of iproveratril (Isoptin) on the cardiovascular system.
Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
[No Abstract] [Full Text] [Related]
3. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
[No Abstract] [Full Text] [Related]
4. Cesium in the prevention of cardiac arrhythmias induced by coronary ligation.
Prasad K; Simani AS; Dolan AM; Sterns LP; Callaghan JC
Surg Forum; 1970; 21():166-7. PubMed ID: 5514720
[No Abstract] [Full Text] [Related]
5. Adrenergic mechanisms in the initiation of cardiac arrhythmias.
Garvey HL
Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):376-90. PubMed ID: 4391896
[No Abstract] [Full Text] [Related]
6. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
Fratz R; Greeff K; Wagner J
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
[No Abstract] [Full Text] [Related]
7. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
Wellens D; Wauters E
Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
[No Abstract] [Full Text] [Related]
8. Effect of verapamil on baroreflex sensitivity and on cardiovascular variability.
Gmitrov J; Andrejko S
Wien Klin Wochenschr; 2000 Feb; 112(4):162-8. PubMed ID: 10726329
[TBL] [Abstract][Full Text] [Related]
9. [Actions of sparteine and sparteine derivatives on the heart and circulation].
Raschack M
Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
[No Abstract] [Full Text] [Related]
10. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
Popova NK; Ivashkevich EI
Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812
[No Abstract] [Full Text] [Related]
11. Effects of iproveratril and nitroglycerin in the heart and coronary circulation of dogs.
Ross G; Jorgensen C
Am Heart J; 1968 Jul; 76(1):74-8. PubMed ID: 4968958
[No Abstract] [Full Text] [Related]
12. Verapamil in cardiology.
Krikler D
Eur J Cardiol; 1974 Aug; 2(1):3-10. PubMed ID: 4153535
[No Abstract] [Full Text] [Related]
13. [Screening of substances with coronary vasodilator action].
Lenke D
Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
[No Abstract] [Full Text] [Related]
14. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
Moret PR; Fournet PC; Boufas D
Schweiz Med Wochenschr; 1970 Mar; 100(10):462-7. PubMed ID: 5423732
[No Abstract] [Full Text] [Related]
16. The effects of coronary vasodilators on coronary and systemic circulation. Experiments on the hearts of anesthetized dogs.
Seta K
Jpn Circ J; 1970 Jun; 34(6):499-511. PubMed ID: 5537669
[No Abstract] [Full Text] [Related]
17. Effect of physostigmine on ventricular fibrillation and myocardial glycogen in hypothermic dogs.
Das PK; Sinha PS
Br J Pharmacol; 1972 Mar; 44(3):391-6. PubMed ID: 5040657
[TBL] [Abstract][Full Text] [Related]
18. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
Angus JA; Brazenor RM; Le Duc MA
Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
[TBL] [Abstract][Full Text] [Related]
19. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
[No Abstract] [Full Text] [Related]
20. [Dependence of pharmacodynamically produced changes of the arteriovenous oxygen difference of the heart on the extracellular pH].
Wolner E; Kraupp O
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):298-309. PubMed ID: 4222747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
